ASHPOfficial

During this episode of ASHP’s Informatics Bytes podcast, we will describe the current state of autoverification, including the reasons and benefits of implementation. The speakers will also be discussing available tools and challenges that should be addressed when considering implementation.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will address opportunities to develop relationships with payers to optimize patient outcomes.  With the expansion of ambulatory care populations health initiatives and prescription-based services, strategic relationships between pharmacy enterprise and payers has become increasingly important.     

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pursuing a residency specializing in pharmacy informatics is emerging as a popular route to begin a career as an informatics pharmacist. Hear from three current PGY2 Pharmacy Informatics Residents about their career path, residency experience, and hopes for training future informatics pharmacists.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

While the utilization of topical hemostatic agents in the emergency department (ED) is dwarfed by its use in OR, ED pharmacists should have a basic understanding of these agents based on the critically ill and surgical patients that can reside in the ED. This podcast will evaluate the available topical hemostatic agents and their place in practice, specifically from the emergency department perspective.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In the Management Case Study, our content matter experts discuss the need for remote work for a world-wide pandemic, identify metrics used to elevate the sustainability of a central pharmacist stagging work model and describe the elements of a successful remote work model for a hospital or health system.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode focuses on the journey to obtaining pharmacist provider status from pharmacy leaders in Minnesota, North Carolina, and Wisconsin who have been advocating on the frontlines. Listen in to learn about the growing need for pharmacist provider status, speakers’ experiences, and advice for those interested in getting involved in pursuing provider status.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In the recent weeks since the Supreme Court issued a decision in Dobbs v. Jackson, there have been widespread media reports of patients experiencing new barriers to access to medication therapies that are seemingly unrelated to reproductive health care or abortion services. During this podcast, we are going to explore the basis of these reports, provide background on the current status of state and federal laws governing access to abortion services, and discuss potential implications for pharmacist practice and patients’ access to medications. Further reading: https://www.ashp.org/news/2022/06/28/ashp-calls-for-patients-rights-to-access-reproductive-health-services?loginreturnUrl=SSOCheckOnly

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Abuse of and addiction to opioid medications continues to be a growing issue worldwide with opioid abuse often beginning with prescribed products in medical care.  Multimodal pain management uses alternatives to opioids to prevent the initial exposure that may lead to addiction and abuse. This podcast is focused on describing the management of acute and chronic pain conditions with opioid sparing modalities and analgesic optimization.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The aim of this podcast is to share the experiences and insights of two pharmacists who have transitioned between clinical practice and academia during their careers. Listeners will gain perspective on the roles/responsibilities associated with clinical versus academic positions, benefits and challenges of each, and factors that contributed to the transitions in the speakers’ practice journeys.     

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field as they discuss barriers and key strategies for biosimilar adoption.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.